Mubadala Bio, a leading life sciences company, is dedicated to enhancing health outcomes in the UAE and globally. The company has announced strategic changes to its executive leadership team, reinforcing its commitment to operational excellence, growth, and innovation.
This leadership update emphasizes Mubadala Bio’s role in advancing the life sciences sector, improving drug security, and ensuring access to essential medical therapies and devices. It also showcases Mubadala’s aim to diversify the UAE economy and promote a knowledge-driven economy through innovation.
Dr. Essam Mohamed has been appointed as the CEO, while Hamad Husein Al Marzooqi takes on the role of Deputy CEO. They are joined by Atif Azeem as CFO and Khalid Abdallah Al-Kaf as General Manager of Pharma Logistics. This team brings a wealth of experience to guide Mubadala Bio’s growth and international influence.
Dr. Bakheet Al Katheeri, CEO of Mubadala’s UAE Investments Platform and Chairman of Mubadala Bio, remarked: “We are thrilled to have leaders of such caliber join Mubadala Bio. Their expertise will be crucial in advancing the life sciences industry in the UAE, driving innovation, and fulfilling our mission for better health access.”
Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala’s UAE Investments Platform, stated: “The life sciences sector is crucial for a resilient future. We trust that Mubadala Bio’s leadership team will achieve transformative outcomes for both the company and the UAE life sciences ecosystem.”
As CEO, Dr. Essam Mohamed will direct Mubadala Bio’s operations and strategy. With over 30 years in the pharmaceutical industry, he has led significant transformations and developed strategies boosting growth and profitability.
Al Marzooqi, with nearly 20 years of leadership experience, has excelled in strategy and business growth across multiple regions. In his new role, he will enhance strategy execution and foster partnerships.
Azeem, with almost 30 years in finance, investments, and treasury, has managed large-scale operations across various sectors. As CFO, he will drive financial strategy and governance.
Abdallah Al-Kaf, with over 20 years in operations and digital transformation, will lead Pharma Logistics, focusing on efficient procurement and distribution of life-saving medications.
Discover more at www.mubadalabio.ae
